The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index; 26 of the 64 sources its claims cite were checked for support.
A tissue-engineered scale model of the heart ventricle
Open accessAbstract
Laboratory studies of the heart use cell and tissue cultures to dissect heart function yet rely on animal models to measure pressure and volume dynamics. Here, we report tissue-engineered scale models of the human left ventricle, made of nanofibrous scaffolds that promote native-like anisotropic myocardial tissue genesis and chamber-level contractile function. Incorporating neonatal rat ventricular myocytes or cardiomyocytes derived from human induced pluripotent stem cells, the tissue-engineered ventricles have a diastolic chamber volume of ~500 µl (comparable to that of the native rat ventricle and approximately 1/250 the size of the human ventricle), and ejection fractions and contractile work 50-250 times smaller and 10 4-10 8 times smaller than the corresponding values for rodent and human ventricles, respectively. We also measured tissue coverage and alignment, calcium-transient propagation and pressure-volume loops in the presence or absence of test compounds. Moreover, we describe an instrumented bioreactor with ventricular-assist capabilities, and provide a proof-of-concept disease model of structural arrhythmia. The model ventricles can be evaluated with the same assays used in animal models and in clinical settings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
33 Own result · 15 Own interpretation · 14 Partly supported · 13 No full text of the sources · 7 No basis given · 4 Supported · 4 Supported so far · 4 Own method · 1 Sources not found · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ejection fractions and contractile work 50–250 times smaller and 104–108 times smaller than the corresponding values for rodent and human ventricles, respectively.”
- Also stated in: § Discussion · plain
“was less than mouse, rat, or human left ventricles by factors of ~104, 105, and 108, respectively24.”
§ A tissue-engineered scale model of the heart ventricle > Abstract
What the sources say
- Partly supportedcites [24] Pacher, P., Nagayama, T., Mukhopadhyay, P., Batkai, S. & Kass, D. A. Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats. Nat. Protoc. 3, 1422–1434 (2008). sourceExperimental — accuracy not yet measured
Table 1 (INTRODUCTION; page unavailable) gives stroke-work values for mouse and rat ventricles, providing rodent reference values. It gives no values for engineered or human ventricles and does not establish that engineered ventricles perform 10^4–10^8 times less contractile work. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) have emerged as a promising tool for in vitro cardiology, with the potential to eliminate interspecies and interpersonal variations through patient-specific derivation8.”
§ A tissue-engineered scale model of the heart ventricle > Introduction
What the sources say
- Supportedcites [8] Karakikes, I., Ameen, M., Termglinchan, V. & Wu, J. C. Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes. Circ. Res. 117, 80–88 (2015). source
The Abstract describes patient-specific iPSC-derived cardiomyocytes as an attractive platform for cardiovascular research and says they could eliminate confounding species-specific and interpersonal variations. This matches the citing sentence’s qualified claim of potential. (LLM, conf=0.95)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Nanofibers provide biochemical and nano-topographical structural cues with sufficient fidelity to guide cell adhesion, orientation, shape, and assembly40,41.”
§ A tissue-engineered scale model of the heart ventricle > Introduction
What the sources say
- Supportedcites [40] Capulli, A. K., MacQueen, L. A., Sheehy, S. P. & Parker, K. K. Fibrous scaffolds for building hearts and heart parts. Adv. Drug Deliv. Rev. 96, 83–102 (2016). source
The Abstract says nanofibrous scaffolds can reproduce high-fidelity nanoscale topography and bioactivity, while ECM structure and biochemistry provide cell-instructive cues. The Introduction describes fibrous substrates influencing cell form and arrangement and links scaffold design to cell adhesion and tissue assembly. Together, these support the paraphrase; page numbers are not available in our copy. (LLM, conf=0.88)
- Partly supportedcites [41] Mauck, R. L. et al. Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration. Tissue Eng. Part B 15, 171–193 (2009). sourceExperimental — accuracy not yet measured
The knee-meniscus case example reports that aligned nanofibrous scaffolds direct cell polarity and promote ordered collagen deposition; “Enhancing cell infiltration” says biologic nanofibers such as collagen provide an environment for cell adhesion. The broader claim that nanofibers generally provide biochemical cues and guide cell shape is not established by these passages; the adhesion point is specifically about biologic fibers. Page numbers are unavailable in our copy. (LLM, conf=0.82)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These values are comparable to those observed in tissues composed of immature cells where cell geometry, calcium handling, gap junction expression and spatial distribution, as well as other factors limit the conduction velocity when compared to mature tissues52,53.”
§ A tissue-engineered scale model of the heart ventricle > Tissue-engineered ventricle chamber
What the sources say
- Partly supportedcites [52] Rohr, S., Kucera, J. P. & Kleber, A. G. Slow conduction in cardiac tissue, I: effects of a reduction of excitability versus a reduction of electrical coupling on microconduction. Circ. Res 83, 781–794 (1998). sourceExperimental — accuracy not yet measured
The Abstract reports conduction velocities in cultured neonatal rat ventricular myocytes and identifies gap-junction coupling and geometry as contributors to slowing. The Minimal Pathlengths Supporting Reentrant Excitation section compares neonatal and adult cell length and gap-junction placement, but does not establish that these features, or calcium handling, make immature tissue conduct more slowly than mature tissue. Its discussion of cell length even predicts slightly higher velocities in cultured cells at a given stage of uncoupling. (LLM, conf=0.86)
- Partly supportedcites [53] Yang, X. L., Pabon, L. & Murry, C. E. Engineering adolescence maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 114, 511–523 (2014). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Given that natural contraction rates of cultured cardiomyocytes are ~60–120 bpm (~1–2 Hz)16,49”
§ A tissue-engineered scale model of the heart ventricle > Ventricle scaffold
What the sources say
- Partly supportedcites [16] Mannhardt, I. et al. Human engineered heart tissue: analysis of contractile force. Stem Cell Rep. 7, 29–42 (2016). sourceExperimental — accuracy not yet measured
The Results (Functional Characterization of hiPSC-EHTs; page unavailable) report that engineered heart tissues followed electrical pacing at 1–2 Hz, but that is not their natural contraction rate. In the same section, the reported spontaneous rate before drug treatment was 47 ± 6 bpm, below the claimed ~60–120 bpm range. The paper also studies a specific engineered-tissue model, not cultured cardiomyocytes generally. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [49] Meiry, G. et al. Evolution of action potential propagation and repolarization in cultured neonatal rat ventricular myocytes. J. Cardiovasc. Electrophysiol. 12, 1269–1277 (2001). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“These features can be recapitulated using nanofibrous materials that are formed into cellular scaffolds with sufficient porosity to support cell infiltration and promote tissue morphogenesis40.”
§ A tissue-engineered scale model of the heart ventricle > Ventricle scaffold
What the sources say
- Supportedcites [40] Capulli, A. K., MacQueen, L. A., Sheehy, S. P. & Parker, K. K. Fibrous scaffolds for building hearts and heart parts. Adv. Drug Deliv. Rev. 96, 83–102 (2016). source
The Introduction says fibrous scaffolds can mimic native extracellular matrix and have adequate porosity for cell infiltration and assembly. Section 3 says nanofibers mimic ECM structure and that scaffold porosity is tuned to allow cellular integration and tissue formation, supporting the paraphrase’s point about tissue morphogenesis. Page numbers are not provided in our copy. (LLM, conf=0.92)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Both NRVM and hiPSC-CM ventricles showed high alignment based on OOP analysis of F-actin stains (Supplementary Fig. 3C), with OOP values of 0. 84 ± 0.02 (NRVM) and 0.85 ± 0.02 (hiPSC-CM).”
§ A tissue-engineered scale model of the heart ventricle > Tissue-engineered ventricle chamber
What the sources say
- Partly supportedcites [35] Feinberg, A. W. et al. Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture. Biomaterials 33, 5732–5741 (2012). sourceExperimental — accuracy not yet measured
The Results (§3.3; page unavailable) report OOP-based alignment in engineered tissues made from neonatal rat ventricular myocytes. They do not report hiPSC-CM ventricles or the stated OOP values for either cell type; the paper calculated OOP from α-actinin-stained sarcomere Z-disks rather than F-actin stains. (LLM, conf=0.84)
- Could not verifycites [54] Pasqualini, F. S., Sheehy, S. P., Agarwal, A., Aratyn-Schaus, Y. & Parker, K. K. Structural phenotyping of stem cell-derived cardiomyocytes. Stem Cell Rep. 4, 340–347 (2015). sourceExperimental — accuracy not yet measured
The Orientational Order Parameter section (p. 7) defines OOP as a measure of alignment, but the paper’s Figure 2 discussion (p. 5) analyzes sarcomeric α-actinin in cardiomyocyte tissues, not F-actin staining in NRVM and hiPSC-CM ventricles. Searches for those ventricle measurements and the values 0.84 ± 0.02 and 0.85 ± 0.02 found no matching passage in our copy. (LLM, conf=0.74)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“To begin, we developed a model cardiac chamber based on tabulated structural and functional properties of the human left ventricle40.”
§ A tissue-engineered scale model of the heart ventricle > Model assumptions for tissue-engineered ventricle chambers
What the sources say
- Supportedcites [40] Capulli, A. K., MacQueen, L. A., Sheehy, S. P. & Parker, K. K. Fibrous scaffolds for building hearts and heart parts. Adv. Drug Deliv. Rev. 96, 83–102 (2016). source
The Abstract says the review tabulated structural and functional properties of myocardial tissues for use as design criteria. Section 2.4 also describes tabulated ventricular properties, including left-ventricular elastance. The citing authors attribute the reference properties—not their own development of the model chamber—to this source. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Healthy ventricular musculature (myocardium) arises from precisely coordinated multiscale integration of physical forces transmitted between cells and the extra-cellular matrix (ECM), as well as between neighboring cells43.”
§ A tissue-engineered scale model of the heart ventricle > Ventricle scaffold
What the sources say
- Partly supportedcites [43] Sheehy, S. P., Grosberg, A. & Parker, K. K. The contribution of cellular mechanotransduction to cardiomyocyte form and function. Biomech. Model. Mechanobiol. 11, 1227–1239 (2012). sourceExperimental — accuracy not yet measured
The Introduction describes mechanical forces transmitted between cells and the ECM, and between neighboring cells, as a possible contributor to the form and function of healthy myocardium. It calls multiscale force propagation “one possible mechanism” and says those forces “could prove vital”; the claim presents that proposed role as an established explanation. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Our observation of isoproterenol-induced stroke work reduction (Fig. 3b) is consistent with negative force-frequency relationships observed in tissues based on immature cardiomyocytes, including NRVM71 and hiPSC-CM72.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
What the sources say
- Not checked — no full text of the sourcecites [71] Zimmermann, W. H. et al. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 68, 106–114 (2000). source
- Supportedcites [72] Germanguz, I. et al. Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J. Cell Mol. Med. 15, 38–51 (2011). source
The cited paper’s “Force frequency relations” section reports that increasing stimulation frequency decreased contraction amplitude in both iPS-CM clones, producing statistically significant negative force–frequency relationships. The citing authors’ isoproterenol-induced stroke work reduction is their own observation, not a result attributed to this source. No page number is provided in our copy. (LLM, conf=0.92)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Probably not a substantial claim. 11
- It may state two separate claims as one. 43
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“animal models and isolated heart preparations are evaluated using pre-clinical and clinical measurement modalities such as catheterization3, echocardiography4, and magnetic resonance imaging5.”
§ A tissue-engineered scale model of the heart ventricle > Introduction
What the sources say
- Partly supportedcites [3] Pacher, P., Nagayama, T., Mukhopadhyay, P., Batkai, S. & Kass, D. A. Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats. Nat. Protoc. 3, 1422–1434 (2008). sourceExperimental — accuracy not yet measured
The Introduction describes catheterization to measure cardiac function in mouse and rat animal models, including intact beating hearts. It does not establish the cited technique's use in isolated heart preparations. Citation 3 is attached to catheterization, so the separate echocardiography and MRI citations are not assessed here. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [4] Ram, R., Mickelsen, D. M., Theodoropoulos, C. & Blaxall, B. C. New approaches in small animal echocardiography: imaging the sounds of silence. Am. J. Physiol. Heart Circ. Physiol. 301, H1765–1780 (2011). source
- Not checked — no full text of the sourcecites [5] Bakermans, A. J. et al. Small animal cardiovascular MR imaging and spectroscopy. Prog. Nucl. Magn. Reson. Spectrosc. 88–89, 1–47 (2015). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Data obtained using these methods allow direct comparison to patient data, but differences in genetics, physiology and disease etiology limit the utility of animal models for developing therapeutic interventions6,7.”
§ A tissue-engineered scale model of the heart ventricle > Introduction
What the sources say
- Not checked — no full text of the sourcecites [6] Chandrasekera, P. C. & Pippin, J. J. The human subject: an integrative animal model for 21st century heart failure research. Am. J. Transl. Res. 7, 1636–1647 (2015).
- Partly supportedcites [7] Gloschat, C. R. et al. Arrhythmogenic and metabolic remodelling of failing human heart. J. Physiol. 594, 3963–3980 (2016). sourceExperimental — accuracy not yet measured
The Introduction says animal models may not reproduce the varied causes of human heart failure and that these differences limit translation to clinical therapies. The Conclusions also identify species and physiological differences as barriers. Our copy does not establish that data obtained using the citing paper’s methods allow direct comparison with patient data, or specifically identify genetic differences between animal models and humans as a barrier. (LLM, conf=0.83)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The myocardial ECM is fibrillar, anisotropic, and provides nanotopographical cues that guide cardiomyocyte alignment and assembly44, ultimately forming a helicoid structure that optimizes ejection fraction during ventricular contraction45.”
§ A tissue-engineered scale model of the heart ventricle > Ventricle scaffold
What the sources say
- Supportedcites [44] Kim, D. H. et al. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc. Natl Acad. Sci. USA 107, 565–570 (2010). source
Citation 44 is attached to the claim about myocardial ECM and cardiomyocyte alignment and assembly, not the subsequent helicoid and ejection-fraction claim attributed to citation 45. The Results describe aligned ECM fibrils whose orientation correlates with adjacent myocardial cells and suggest that the ECM provides nanotopographic cues guiding alignment; they also report that nanoscale patterns guide cell monolayers into an aligned architecture. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [45] Savadjiev, P. et al. Heart wall myofibers are arranged in minimal surfaces to optimize organ function. Proc. Natl Acad. Sci. USA 109, 9248–9253 (2012). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Engineered cardiac organoid chambers comprised of cardiomyocytes embedded in isotropic hydrogels showed significant promise for obtaining intra-ventricular pressure measurements26–29 but the lack of a scaffold to guide cell assembly hampers the formation of organized tissues that recapitulate the laminar architecture30,31 of the native myocardium.”
§ A tissue-engineered scale model of the heart ventricle > Introduction
What the sources say
- Not checked — no full text of the sourcecites [26] Lee, E. J., Kim do, E., Azeloglu, E. U. & Costa, K. D. Engineered cardiac organoid chambers: toward a functional biological model ventricle. Tissue Eng. Part A 14, 215–225 (2008). source
- Not checked — no full text of the sourcecites [27] Gonen-Wadmany, M., Gepstein, L. & Seliktar, D. Controlling the cellular organization of tissue-engineered cardiac constructs. Ann. N. Y. Acad. Sci. 1015, 299–311 (2004). source
- Not checked — no full text of the sourcecites [28] Yildirim, Y. et al. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 116, I-16–I-23 (2007). source
- Partly supportedcites [29] Li, R. A. et al. Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells. Biomaterials 163, 116–127 (2018). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [30] Costa, K. D., Takayama, Y., McCulloch, A. D. & Covell, J. W. Laminar fiber architecture and three-dimensional systolic mechanics in canine ventricular myocardium. Am. J. Physiol. 276, H595–607 (1999). source
- Not checked — no full text of the sourcecites [31] Arts, T., Costa, K. D., Covell, J. W. & McCulloch, A. D. Relating myocardial laminar architecture to shear strain and muscle fiber orientation. Am. J. Physiol. Heart Circ. Physiol. 280, H2222–2229 (2001). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We selected polycaprolactone (PCL)/gelatin nanofibers as our material of choice because they are biocompatible and biodegradable, they promote cell adhesion, provide sufficient structural integrity for ventricle culture and catheterization, and can be produced by a variety of nanofiber production systems that include electrospinning and force-spinning methods40.”
§ A tissue-engineered scale model of the heart ventricle > Ventricle scaffold
What the sources say
- Partly supportedcites [40] Capulli, A. K., MacQueen, L. A., Sheehy, S. P. & Parker, K. K. Fibrous scaffolds for building hearts and heart parts. Adv. Drug Deliv. Rev. 96, 83–102 (2016). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the native heart, overlapping myocardial fibers are arranged into distinct laminae four to six myocytes thick and separated from adjacent laminae by an extracellular collagen network42.”
§ A tissue-engineered scale model of the heart ventricle > Model assumptions for tissue-engineered ventricle chambers
What the sources say
- Partly supportedcites [42] Pope, A. J., Sands, G. B., Smaill, B. H. & LeGrice, I. J. Three-dimensional transmural organization of perimysial collagen in the heart. Am. J. Physiol. Heart C 295, 1243–1252 (2008). sourceExperimental — accuracy not yet measured
The Discussion (3-D perimysial collagen organization; page unavailable) describes branching myocardial layers grouped by perimysial collagen and reports them as approximately four cells thick, not four to six. The Results (page unavailable) show collagen between adjacent layers, but the paper also says laminar structure is not evident in the outer 10–20% of the rat left ventricle, so the claim is too general. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Cardiomyocyte spontaneous beat rates in our model ventricles were similar to other in vitro assays based on NRVM49 or hiPSC-CM16, showing moderate positive chronotropy (~40% beat rate)10,18.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
What the sources say
- Not checked — no full text of the sourcecites [49] Meiry, G. et al. Evolution of action potential propagation and repolarization in cultured neonatal rat ventricular myocytes. J. Cardiovasc. Electrophysiol. 12, 1269–1277 (2001). source
- Supportedcites [16] Mannhardt, I. et al. Human engineered heart tissue: analysis of contractile force. Stem Cell Rep. 7, 29–42 (2016). source
The citation to this paper is attached to the hiPSC-CM assay, not the later ~40% positive-chronotropy claim, which has separate citations. The Results (Functional Characterization of hiPSC-EHTs) describe spontaneously beating hiPSC-derived heart tissues and report a baseline rate of 47 ± 6 bpm, supporting its use as an example of that assay. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [10] Eder, A., Vollert, I., Hansen, A. & Eschenhagen, T. Human engineered heart tissue as a model system for drug testing. Adv. Drug Deliv. Rev. 96, 214–224 (2016). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The moderate positive chronotropy and reduction of stroke work observed at high isoproterenol doses are characteristic of immature tissues exhibiting poorly developed calcium handling properties8, suggesting that maturation protocols14,21,22,73 may be required to obtain positive force-frequency relationships, as observed in healthy adult human ventricular myocardium74.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
What the sources say
- Partly supportedcites [8] Karakikes, I., Ameen, M., Termglinchan, V. & Wu, J. C. Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes. Circ. Res. 117, 80–88 (2015). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [14] Nunes, S. S. et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 10, 781–787 (2013). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [74] Endoh, M. Force–frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance. Eur. J. Pharmacol. 500, 73–86 (2004). source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Contractile work in our ventricle models was measured using conductance catheters and was smaller than reported for cardiac organoid chambers based on NRVM26 or pluripotent hES2 human embryonic stem cell-derived cardiomyocytes29, where volume changes were indirectly assessed from video recordings.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
What the sources say
- Not checked — no full text of the sourcecites [26] Lee, E. J., Kim do, E., Azeloglu, E. U. & Costa, K. D. Engineered cardiac organoid chambers: toward a functional biological model ventricle. Tissue Eng. Part A 14, 215–225 (2008). source
- Supportedcites [29] Li, R. A. et al. Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells. Biomaterials 163, 116–127 (2018). source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, the tensile elastic modulus of our scaffold in the direction of fiber alignment (EL ~ 500 kPa) was higher than healthy ventricular ECM (E ~350 kPa)68 and may have limited cardiomyocyte shortening during contraction.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
What the sources say
- Partly supportedcites [68] Quinn, K. P. et al. Optical metrics of the extracellular matrix predict compositional and mechanical changes after myocardial infarction. Sci. Rep. 6, 35823 (2016). sourceExperimental — accuracy not yet measured
The Results report tensile testing of healthy ventricular ECM and its elastic modulus, supporting the use of this paper as a comparator. But the available text does not give the cited value of approximately 350 kPa (searched: “350” and “kPa”). The scaffold modulus and possible effect on cardiomyocyte shortening are the citing authors’ own comparison and inference, not findings attributed to this source. (LLM, conf=0.83)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Incorporating neonatal rat ventricular myocytes or cardiomyocytes derived from human induced pluripotent stem cells, the tissue-engineered ventricles have a diastolic chamber volume of ~500 μL (comparable to that of the native rat ventricle and approximately 1/250 the size of the human ventricle)”
§ A tissue-engineered scale model of the heart ventricle > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here, we report tissue-engineered scale models of the human left ventricle, made of nanofibrous scaffolds that promote native-like anisotropic myocardial tissue genesis and chamber-level contractile function.”
§ A tissue-engineered scale model of the heart ventricle > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In all cases, spontaneous calcium activity showed stable excitation patterns with plane waves (healthy) or pinned spiral waves (injured) repeating at a near-constant rate (between 4 Hz and 5Hz) for the duration of experiments (~2 hours).”
§ A tissue-engineered scale model of the heart ventricle > Structural arrhythmia disease model
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pressure/volume loops measured before and after isoproterenol exposure showed an isoproterenol-induced reduction in stroke work, concomitant with an increase in beat frequency (Fig. 3b,c).”
§ A tissue-engineered scale model of the heart ventricle > Intra-ventricular pressure and volume measurements
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Plane wave propagation was observed prior to injury (Fig. 5a, top), whereas injured ventricles generated spiral waves that were pinned to the controlled anatomical defects (Fig. 5a, bottom panels, and Supplementary Movie 12).”
§ A tissue-engineered scale model of the heart ventricle > Structural arrhythmia disease model
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The HBR includes both intra- and extra- ventricular flow loops, separate chambers for optional valve inserts, and additional access ports for catheters (Fig. 4a, Supplementary Fig. S8).”
§ A tissue-engineered scale model of the heart ventricle > Bioreactor for modular assembly of ventricles and valves
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mean calcium wavefront propagation velocity from apex to base was 9.33 cm/sec or 5.2 cm/sec for NRVM or hiPSC-CM ventricles, respectively.”
§ A tissue-engineered scale model of the heart ventricle > Tissue-engineered ventricle chamber
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The resulting tissue-engineered ventricle chambers were sutured to tubing or bioreactor components through which catheter sensors were introduced and stable contraction of both NRVM and hiPSC-CM ventricles permitted time-dependent pressure and volume measurements.”
§ A tissue-engineered scale model of the heart ventricle > Introduction
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In our scaffold, gelatin was used to enhance cell and biomolecule adhesion during cell seeding, and the polymer backbone (PCL) provided structural features (microporosity, nanotopography, anisotropy) that resisted degradation during culture.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Calcium fluorescence intensity measured near the rotor poles of a single-hole injury model showed consistent phase difference and a rotation rate of ~ 5 Hz (Fig. 5b, Supplementary Figure S12, and Supplementary Movie 13).”
§ A tissue-engineered scale model of the heart ventricle > Structural arrhythmia disease model
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Using small animal echocardiography equipment, we recorded both unassisted natural spontaneous ventricle contraction (Fig. 4c, left, and Supplementary Movie 10) and HBR-assisted contraction (Fig. 4c, right, and Supplementary Movie 11).”
§ A tissue-engineered scale model of the heart ventricle > Bioreactor for modular assembly of ventricles and valves
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Measured differences in chamber pressure were ~50 μmHg (rat or human) and the volume change was ~5 μL (rat) or 1 μL (human).”
§ A tissue-engineered scale model of the heart ventricle > Intra-ventricular pressure and volume measurements
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Synchronous, coordinated ventricle contraction developed spontaneously after 3–5 days of culture (Supplementary Movies 3,4) and persisted for the duration of experimental procedures (Supplementary Movie 5), conducted 14 days after seeding.”
§ A tissue-engineered scale model of the heart ventricle > Tissue-engineered ventricle chamber
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cyclic pressure applied to the extra-ventricular loop drives intra-ventricular fluid flow via assisted ventricle contraction, and unidirectional flow can be achieved using commercially available valves or with custom valve inserts in the HBR.”
§ A tissue-engineered scale model of the heart ventricle > Bioreactor for modular assembly of ventricles and valves
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
§ A tissue-engineered scale model of the heart ventricle > Intra-ventricular pressure and volume measurements
What the sources say
- Not checked — no full text of the sourcecites [59] Simpson, P. & Savion, S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ. Res. 50, 101–116 (1982). source
- Not checked — no full text of the sourcecites [60] Moretti, A. et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397–1409 (2010). source
- Not checked — no full text of the sourcecites [61] Koglin, J., Bohm, M., Vonscheidt, W., Stablein, A. & Erdmann, E. Antiadrenergic effect of carbachol but not of adenosine on contractility in the intact human ventricle in-vivo. J. Am. Coll. Cardiol. 23, 678–683 (1994). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The spontaneous beat rate of NRVM ventricles (~130 ±15 bpm) was higher than hiPSC-CM ventricles (~85 ± 15 bpm), and both increased by ~40% following exposure to 10−4 M isoproterenol.”
§ A tissue-engineered scale model of the heart ventricle > Intra-ventricular pressure and volume measurements
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These features provided sufficient structural integrity for ventricle culture and they guided cardiomyocyte assembly”
§ A tissue-engineered scale model of the heart ventricle > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Thus, ejection fractions were ~1% (rat) or ~0.2% (human) and stroke work was WS ~ 0.25 mmHg × μL (rat) or WS ~ 0.05 mmHg × μL (human).”
§ A tissue-engineered scale model of the heart ventricle > Intra-ventricular pressure and volume measurements
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Whereas regular beat frequencies were observed in calcium-containing M199 or Tyrode’s solution, exposure to calcium-free PBS led to broad beat rate distributions (Supplementary Fig. S7B).”
§ A tissue-engineered scale model of the heart ventricle > Intra-ventricular pressure and volume measurements
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also cultured a non-proliferative hiPSC-CM line (Cor.4U) in model ventricle scaffolds for 6 months, demonstrating that tissue anisotropy was preserved (Supplementary Figure S14A) and stable pressure-volume loops could be recorded (Supplementary Figure S14 B).”
§ A tissue-engineered scale model of the heart ventricle > Discussion
boostedSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When cultured in differentiation media, the resulting hiPSC-CM showed spontaneous contraction and early stages of sarcomeric assembly within 8–12 days of culture (Supplementary Figure S13A, Day 12), and anisotropic sarcomeric assembly with early stages of z-disk alignment after 1 month in culture (Supplementary Figure S13A, Day 30).”
§ A tissue-engineered scale model of the heart ventricle > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Both types of model cardiac chambers generated similarly shaped elliptical PV-loops (Fig. 3b, Supplementary Fig. S14), which are expected from ventricles contracting in the absence of valves and show similarities to PV loops obtained from patients with severe valvular insufficiencies78.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
What the sources say
- Not matchedcites [78] Klabunde, R. E. Cardiovascular Physiology Concepts 2nd edn (Lippincott Williams & Wilkins/Wolters Kluwer, Philadelphia, 2012).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The EF of our tissue-engineered rat ventricles was ~1% (1/50 EF of healthy rats), suggesting that discontinuities in cardiomyocyte coverage limited tissue-engineered ventricle contractile strength.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“We observed a non-linear conductance/volume catheter response (Supplementary Fig. 4B.i), as expected for these systems82.”
§ A tissue-engineered scale model of the heart ventricle > Methods > Pressure-Volume Measurements
What the sources say
- Not checked — no full text of the sourcecites [82] Pearce, J. A., Porterfield, J. E., Larson, E. R., Valvano, J. W. & Feldman, M. D. Accuracy considerations in catheter based estimation of left ventricular volume. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2010, 3556–3558 (2010). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Both showed evidence of spontaneously generated calcium plane wave propagation but one had greater homogeneity; this favorable sample is reported in our revised manuscript.”
§ A tissue-engineered scale model of the heart ventricle > Methods > Optical mapping experiments
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The cell density in our ventricles, estimated by counting immunostained (DAPI) NRVM ventricle surfaces and cross-sections (Supplementary Fig. S3), was ~90,000 cells/mm3 for a total cell number ~2.3 × 106 in a 26 mm3 scaffold volume, which is approximately 10-fold less than in 21-day-old or 3-month-old rat hearts75.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
What the sources say
- Not checked — no full text of the sourcecites [75] Bai, S. L., Campbell, S. E., Moore, J. A., Morales, M. C. & Gerdes, A. M. Influence of age, growth, and sex on cardiac myocyte size and number in rats. Anat. Rec. 226, 207–212 (1990). source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“but direct comparison with natural ventricle pressure and volume dynamics requires three-dimensional (3D) contractile cardiac chambers.”
§ A tissue-engineered scale model of the heart ventricle > Introduction
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“These cells are assembled into functional engineered heart tissues2,9,10, including muscular thin films11,12 or 3D muscle strips13–20, to model contractile pathophysiologies11, promote hiPSC-CM maturation9,14,15,21, and produce drug responses that are increasingly comparable to human patients16,18,22.”
§ A tissue-engineered scale model of the heart ventricle > Introduction
What the sources say
- Not checked — no full text of the sourcecites [2] Tzatzalos, E., Abilez, O. J., Shukla, P. & Wu, J. C. Engineered heart tissues and induced pluripotent stem cells: macro- and microstructures for disease modeling, drug screening, and translational studies. Adv. Drug Deliv. Rev. 96, 234–244 (2016). source
- Not checked — no full text of the sourcecites [9] Feric, N. T. & Radisic, M. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv. Drug Deliv. Rev. 96, 110–134 (2016). source
- Not checked — no full text of the sourcecites [10] Eder, A., Vollert, I., Hansen, A. & Eschenhagen, T. Human engineered heart tissue as a model system for drug testing. Adv. Drug Deliv. Rev. 96, 214–224 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These and other limitations associated with animal models, for example high maintenance costs and low experimental throughput, motivate the development of alternative in vitro cardiology assays based on human cells.”
§ A tissue-engineered scale model of the heart ventricle > Introduction
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These properties allowed us to fabricate ventricle scaffolds that were both structurally stable and permissive to chamber contraction by cardiomyocyte shortening.”
§ A tissue-engineered scale model of the heart ventricle > Ventricle scaffold
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Echocardiography performed in the absence of extra-ventricular tissues can improve image clarity compared with in vivo studies, underscoring the advantage of organ modularity in our HBR.”
§ A tissue-engineered scale model of the heart ventricle > Bioreactor for modular assembly of ventricles and valves
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this configuration, cultured ventricles can be exposed to externally-controlled physiological or pathological pressure variations and PV loops acquired with or without valves (Fig. 4b)”
§ A tissue-engineered scale model of the heart ventricle > Bioreactor for modular assembly of ventricles and valves
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“We previously described anisotropic PCL/gelatin nanofiber production by pull spinning and their use to guide skeletal muscle tissue assembly46.”
§ A tissue-engineered scale model of the heart ventricle > Ventricle scaffold
What the sources say
- Not checked — no full text of the sourcecites [46] Deravi, L. F. et al. Design and fabrication of fibrous nanomaterials using pull spinning. Macromol. Mater. Eng. 302, 1600404 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Scaffold engineering should account for the fact that the myocardium is a composite in which the dominant stiffness shifts from myocytes to the ECM with increasing strain67, emphasizing the ECM’s role maintaining structural integrity.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
What the sources say
- Not checked — no full text of the sourcecites [67] Chaturvedi, R. R. et al. Passive stiffness of myocardium from congenital heart disease and implications for diastole. Circulation 121, 979–988 (2010). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These results have implications for preclinical cardiology and regenerative medicine research where human organ models are sought to improve translation of therapeutic strategies.”
§ A tissue-engineered scale model of the heart ventricle > Introduction
plain- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“A fundamental aspect of myocardial function is the response to adrenergic agonists, which has been studied extensively in both rodents and humans, making β-adrenergic response a good test of the ability of our engineered ventricles to recapitulate normal cardiac pharmacology57,58.”
§ A tissue-engineered scale model of the heart ventricle > Intra-ventricular pressure and volume measurements
What the sources say
- Not checked — no full text of the sourcecites [57] Barrett, A. M. & Carter, J. Comparative chronotropic activity of beta-adrenoceptive antagonists. Br. J. Pharmacol. 40, 373–381 (1970). source
- Not checked — no full text of the sourcecites [58] Brito-Martins, M., Harding, S. E. & Ali, N. N. Beta(1)- and beta(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. Br. J. Pharmacol. 153, 751–759 (2008). source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“while gelatin was chosen as an RGD-containing biopolymer derived from denatured collagen that improves scaffold binding to cells and biomolecules such as fibronectin47,48.”
§ A tissue-engineered scale model of the heart ventricle > Ventricle scaffold
What the sources say
- Not checked — no full text of the sourcecites [47] Ruoslahti, E. RGD and other recognition sequences for integrins. Annu Rev. Cell Dev. Biol. 12, 697–715 (1996). source
- Not checked — no full text of the sourcecites [48] Katagiri, Y., Brew, S. A. & Ingham, K. C. All six modules of the gelatin-binding domain of fibronectin are required for full affinity. J. Biol. Chem. 278, 11897–11902 (2003). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These preliminary results suggest that our scaffolds support functional myocardial tissue production using relatively small numbers of seeded hiPSC that can subsequently be cultured for extended time periods.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Our use of conductance catheters was advantageous for direct volume readouts but electrical pacing during catheterization was not recommended by the catheter manufacturer and therefore not performed in these studies.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All procedures were approved by the Harvard Animal Care and Use Committee”
§ A tissue-engineered scale model of the heart ventricle > Methods > Experimental animals
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our work suggests that including a nanofibrous component to printable inks would be advantageous for directing cardiomyocyte shape and assembly in printed scaffolds or tissues.”
§ A tissue-engineered scale model of the heart ventricle > Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it.
The authors state this as an assumption.
The scale-model ventricle would have a diastolic chamber volume of about 500 microliters, about twice that of a rat and about 1/250 that of a human.
“We would build a scale-model of the human left ventricle chamber with diastolic chamber volume ~500 microliters (~2 × rat, ~1/250 human)”
The authors state this as an assumption.
The ventricle wall would not be vascularized and its thickness would be limited to about 0.1 mm to maintain high cell viability in a diffusion-limited environment.
“the ventricle wall would not be vascularized and its thickness limited to ~0.1 mm (~1/10 rat, ~1/100 human) to maintain high cell viability within the diffusion-limited environment”
The authors state this as an assumption.
The ventricle scaffold material would be a well-known protein-polymer mixture to ensure production reproducibility using existing nanofiber systems.
“the ventricle scaffold material would be a well-known protein-polymer mixture to ensure production reproducibility using existing nanofiber systems”
The authors state this as an assumption.
Cardiomyocyte alignment would be circumferential throughout the scaffold, representing a thin-walled approximation of the helical alignment within the native ventricular wall.
“cardiomyocyte alignment would be circumferential throughout the scaffold, representing a thin walled approximation of the helical alignment within the native ventricular wall.”
The paper relies on this without support.
The rat is the current industry standard for studying heart disease in vitro and in vivo.
“rat is the current industry standard for the study of heart disease in vitro and in vivo”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“However, they only cultivated pure cardiomyocytes within 14 days after seeding.”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [20]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We calculated our hiPSC-CM based ventricular volumetric change between peak contraction and peak relaxation to be 5.94 ± 1.66 % (n = 4, mean ± SEM, Fig. 4g), which is 2~5 and 8~20 times higher than values previously reported (ejection fraction) for NRVM and hiPSC-CM in vitro ventricle models, respectively13, 15, 32.”
From Fibre-infused gel scaffolds guide cardiomyocyte alignment in 3D-printed ventricles (2023) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, these tissues are limited to a single ventricle model and thus lack the capacity for perfusion.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Wall thicknesses on the low end of this spectrum match what has been previously demonstrated in the literature, and the high end of the spectrum far exceeds existing tissue models6–8.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Engineered cardiac chambers have emerged to address this gap, enabling physiologically relevant pressure-volume measurements and capturing both contractile and diastolic dynamics that mimic aspects of native cardiac hemodynamics.”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, Michas et al. and Macqueen et al. successfully incorporated valves into microfluidic and bioreactor platforms, respectively, with Michas et al. demonstrating unidirectional flow and MacQueen et al. reporting improved PV loop morphology as a result of valve presence (Michas et al., 2022; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An additional disease model, a structural arrhythmia model induced by cryoinjury, was described by MacQueen et al. (2018). This approach produced pinned spiral wave patterns that are consistent with clinical arrhythmia phenotypes.”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These models more closely resemble the structural architecture of the heart, pump fluid, allow for analysis of Pressure-Volume (PV) readouts, facilitate control of preload and afterload, and are exposed to multiaxial stress (Li et al., 2018; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, Michas et al. and Macqueen et al. successfully incorporated valves into microfluidic and bioreactor platforms, respectively, with Michas et al. demonstrating unidirectional flow and MacQueen et al. reporting improved PV loop morphology as a result of valve presence (Michas et al., 2022; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These models more closely resemble the structural architecture of the heart, pump fluid, allow for analysis of Pressure-Volume (PV) readouts, facilitate control of preload and afterload, and are exposed to multiaxial stress (Li et al., 2018; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Anatomically, select models have incorporated functional valves, producing more physiological PV loops (MacQueen et al., 2018; Michas et al., 2022).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Simultaneous PV measurements are currently limited to invasive micro-catheter systems adapted from in vivo mouse experiments (Li et al., 2018; MacQueen et al., 2018; Kupfer et al., 2020; Mohammadi et al., 2022).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While this scaffold-based approach facilitated enhanced CM orientation, the rigidity and non-degradable nature of the scaffolds hampered cellular self-organization and matrix self-determination, preventing the cells from forming a cohesive tissue and impairing the full potential contractility of the cardiomyocytes.”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, valve-less engineered cardiac chambers exhibit less distinct delays between pressure and volume fluctuations during beating cycles, typically leading to narrower, elliptical PV-loop patterns (R. A. Li et al., 2018;Macqueen et al., 2018).”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While there are a few models that can effectively mimic the pumping function of the heart, they are typically associated with significant cost and labor intensity.[ 19 , 20 ]”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Starting with the frequency changes, we can confirm data showing an increase of around 88% after 10 µM ISO treatment reported by Hamad et al.[ 17 ] and around 15 % reported by MacQueen et al.,[ 20 ] with measurements showing an increase of 30.6 to 45.9%.”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mean beating frequency in their model was about 85 bpm,[ 20 ] which is comparable to our engineered ventricles.”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MacQueen et al. generated a ventricle model by seeding human cardiomyocytes onto an electrospun ventricle scaffold and measured a volume change during a contraction cycle of approximately 0.4 µL.[ 20 ]”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Because fiber-spinning techniques can reproduce these fine spatial features with higher throughputs, they offer a potential solution and have been used previously to engineer tissue scaffolds, such as heart valves (23) and ventricle models (24).”
From Recreating the heart's helical structure-function relationship with focused rotary jet spinning (2022) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“These values were consistent with previous reports of in vitro tissues composed of immature cardiomyocytes, where factors such as geometry, calcium handling, and gap junction expression can influence CV (24, 34, 35).”
From Recreating the heart's helical structure-function relationship with focused rotary jet spinning (2022) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Although the metrics presented here (e.g., EF) were greater (by a factor of ~3) than for recently reported in vitro ventricle models (24, 39), they were still substantially lower than in vivo values (tables S2 and S3).”
From Recreating the heart's helical structure-function relationship with focused rotary jet spinning (2022) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, multiple existing single ventricle models rely on their simple cup-like geometry to enable casting of a cardiomyocyte-laden gel6 or seeding of cardiomyocytes after fabrication7.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“To address this issue, researchers have made strides in the generation of volume-handling cardiac tissue models capable of recapitulating pressure-volume dynamics of the heart6–8.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“These measurements are on par with data shown in single ventricle models6, 7.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Notably, we show that the hChaMP can maintain these functions for at least 6 weeks, while most similar models have been characterized only up to 2 weeks after fabrication6–8, 18.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“similar to results reported by MacQueen et al., we show that the hChaMP can respond to a range of isoproterenol doses7.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“the pressure generated by the hChaMP, while low (0.23 mmHg), is higher than other reported values6, 7.”
From In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid (2020) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“These models more closely resemble the structural architecture of the heart, pump fluid, allow for analysis of Pressure-Volume (PV) readouts, facilitate control of preload and afterload, and are exposed to multiaxial stress (Li et al., 2018; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“These models more closely resemble the structural architecture of the heart, pump fluid, allow for analysis of Pressure-Volume (PV) readouts, facilitate control of preload and afterload, and are exposed to multiaxial stress (Li et al., 2018; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“Incorporation of valves is critical for reproducing physiologic PV loops and ensuring unidirectional flow (MacQueen et al., 2018; Michas et al., 2022).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“These models more closely resemble the structural architecture of the heart, pump fluid, allow for analysis of Pressure-Volume (PV) readouts, facilitate control of preload and afterload, and are exposed to multiaxial stress (Li et al., 2018; MacQueen et al., 2018).”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as MacQueen et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“However, current fabrication approaches used to create these engineered ventricular chambers, including molding (R. A. Li et al., 2018), scaffold-seeding (Macqueen et al., 2018;Michas et al., 2022;Mohammadi et al., 2022;Patel & Birla, 2018) and bioprinting (Kupfer et al., 2020;Lee et al., n.d.) have significant limitations that hamper their use.”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, functional characterization of current engineered ventricles is often done utilizing conductance catheters (Kupfer et al., 2020;R. A. Li et al., 2018;Macqueen et al., 2018), which come with high costs, low accessibility and incompatibility with electrical pacing (Baan et al., 1985;Wei et al., 2014).”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“Although far from human ejection fraction values (50%-70%), the ejection fractions of our mini-heart (~1%-3%) are in the same range as other reported models (0.2%-9.6%) (Kupfer et al., 2020;R. A. Li et al., 2018;Macqueen et al., 2018;Michas et al., 2022).”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“However, the observed negative force-frequency relationship is consistent with findings in similar models (R. A. Li et al., 2018;Macqueen et al., 2018) and suggests the calcium handling of hPSC-CMs still requires further maturation.”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“The mini-hearts demonstrated stroke works of ~0.10 -~0.18 µJ which, to our knowledge, are the highest stroke work values compared to other engineered ventricles (6 nJ-57 nJ) (Kupfer et al., 2020;R. A. Li et al., 2018;Macqueen et al., 2018).”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Macqueen et al., 2018
In the citing paper
“Recent examples have also demonstrated that the introduction of electrical barriers such as holes in healthy cardiac tissue or fibroblast dense regions disrupts action potential propagation46,52.”
From 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels (2021) · cites this paper as [52]
Citations
Cites
Methods of Theoretical Physics
Morse, P. M., Feshbach, H., & Hill, E. L. (1954) · American Journal of Physics · doi:10.1119/1.1933765 · Cited by 13,197
Akselrod, S., Gordon, D., Ubel, F. A., Shannon, D. C., Berger, A. C., & Cohen, R. J. (1981) · Science · doi:10.1126/science.6166045 · Cited by 5,079
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000433566 · Cited by 3,519
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191
Sydney Gladman, A., Matsumoto, E. A., Nuzzo, R. G., Mahadevan, L., & Lewis, J. A. (2016) · Nature Materials · doi:10.1038/nmat4544 · Cited by 3,027
Self-citationAdvanced maturation of human cardiac tissue grown from pluripotent stem cells
Ronaldson-Bouchard, K., Ma, S. P., Yeager, K., Chen, T., Song, L., Sirabella, D., Morikawa, K., Teles, D., Yazawa, M., & Vunjak-Novakovic, G. (2018) · Nature · doi:10.1038/s41586-018-0016-3 · Cited by 1,272
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias
KLÉBER, A. G., & RUDY, Y. (2004) · Physiological Reviews · doi:10.1152/physrev.00025.2003 · Cited by 1,083
Vascularization is the key challenge in tissue engineering
Novosel, E. C., Kleinhans, C., & Kluger, P. J. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.004 · Cited by 1,067
Biowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes
Nunes, S. S., Miklas, J. W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang, J., Massé, S., Gagliardi, M., Hsieh, A., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2524 · Cited by 952
Research works printed but not linked: 2
- Pacher, P., Nagayama, T., Mukhopadhyay, P., Batkai, S. & Kass, D. A. Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats. Nat. Protoc. 3, 1422–1434 (2008). · DOI · Paper page
- Klabunde, R. E. Cardiovascular Physiology Concepts 2nd edn (Lippincott Williams & Wilkins/Wolters Kluwer, Philadelphia, 2012).
Cited by
Sorted by citations
A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Zhao, Y., Rafatian, N., Feric, N. T., Cox, B. J., Aschar-Sobbi, R., Wang, E. Y., Aggarwal, P., Zhang, B., Conant, G., Ronaldson-Bouchard, K., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.042 · Cited by 610
“…(hPSC) have focused on generating ventricular myocardium (Ahn et al., 2018; Eschenhagen et al., 2012; Lemoine et al., 2017; Lind et al., 2017a; MacQueen et al., 2018; Nunes et al., 2013; Schaaf et al., 2011; Tulloch et al., 2011); (Lemoine et al., 2018; Lind et al., 2017b; Tiburcy et al.,…”
Daly, A. C., Davidson, M. D., & Burdick, J. A. (2021) · Nature Communications · doi:10.1038/s41467-021-21029-2 · Cited by 470
Kupfer, M. E., Lin, W.-H., Ravikumar, V., Qiu, K., Wang, L., Gao, L., Bhuiyan, D. B., Lenz, M., Ai, J., Mahutga, R. R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316155 · Cited by 329
Santos, D. M. D., Correa, D. S., Medeiros, E. S. D., de Oliveira, J. E., & Mattoso, L. H. C. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12410 · Cited by 240
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
Goldfracht, I., Efraim, Y., Shinnawi, R., Kovalev, E., Huber, I., Gepstein, A., Arbel, G., Shaheen, N., Tiburcy, M., Zimmermann, W. H., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.016 · Cited by 222
Fibre-infused gel scaffolds guide cardiomyocyte alignment in 3D-printed ventricles
Choi, S., Lee, K. Y., Kim, S. L., MacQueen, L. A., Chang, H., Zimmerman, J. F., Jin, Q., Peters, M. M., Ardoña, H. A. M., Liu, X., et al. (2023) · Nature Materials · doi:10.1038/s41563-023-01611-3 · Cited by 212
Self-citationMuscle tissue engineering in fibrous gelatin: implications for meat analogs
MacQueen, L. A., Alver, C. G., Chantre, C. O., Ahn, S., Cera, L., Gonzalez, G. M., O’Connor, B. B., Drennan, D. J., Peters, M. M., Motta, S. E., et al. (2019) · npj Science of Food · doi:10.1038/s41538-019-0054-8 · Cited by 214
Self-citationWan, X., Zhao, Y., Li, Z., & Li, L. (2022) · Exploration · doi:10.1002/exp.20210029 · Cited by 189
Mastikhina, O., Moon, B., Williams, K., Hatkar, R., Gustafson, D., Mourad, O., Sun, X., Koo, M., Lam, A. Y. L., Sun, Y., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119741 · Cited by 192
Challenges and opportunities for the next generation of cardiovascular tissue engineering
Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G., & Wu, J. C. (2022) · Nature Methods · doi:10.1038/s41592-022-01591-3 · Cited by 176
Silva, A. C., Rubio, O., Joy, D. A., Kauss, M. A., Natarajan, V., Lai, M. H., Turaga, D., Blair, A. P., Alexanian, M., Bruneau, B. G., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.11.007 · Cited by 185
Fang, Y., Guo, Y., Wu, B., Liu, Z., Ye, M., Xu, Y., Ji, M., Chen, L., Lu, B., Nie, K., et al. (2023) · Advanced Materials · doi:10.1002/adma.202205082 · Cited by 155
Ahrens, J. H., Uzel, S. G. M., Skylar‐Scott, M., Mata, M. M., Lu, A., Kroll, K. T., & Lewis, J. A. (2022) · Advanced Materials · doi:10.1002/adma.202200217 · Cited by 143
Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering
Tenreiro, M. F., Louro, A. F., Alves, P. M., & Serra, M. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00140-4 · Cited by 153
Recreating the heart's helical structure-function relationship with focused rotary jet spinning
Chang, H., Liu, Q., Zimmerman, J. F., Lee, K. Y., Jin, Q., Peters, M. M., Rosnach, M., Choi, S., Kim, S. L., Ardoña, H. A. M., et al. (2022) · Science · doi:10.1126/science.abl6395 · Cited by 131
Self-citationBliley, J. M., Vermeer, M. C. S. C., Duffy, R. M., Batalov, I., Kramer, D., Tashman, J. W., Shiwarski, D. J., Lee, A. R., Teplenin, A. S., Volkers, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd1817 · Cited by 139
Passive myocardial mechanical properties: meaning, measurement, models
Emig, R., Zgierski-Johnston, C. M., Timmermann, V., Taberner, A. J., Nash, M. P., Kohl, P. K., & Peyronnet, R. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00838-1 · Cited by 139
“The embryonic murine heart stiffens progressively, from < 1 kPa for the cardiac tube to 10 kPa in embryos aged E2 to E14 (Majkut et al. 2013, 2014; Chiou et al. 2016), as assessed by micropipette aspiration and computationally.”
BackgroundBiomaterializing the promise of cardiac tissue engineering
Pomeroy, J. E., Helfer, A., & Bursac, N. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.009 · Cited by 108
“A modified electrospinning method was also used to generate single ventricle human fECTs which the authors cultured in a specialized bioreactor that allowed for continuous hemodynamic monitoring (MacQueen et al., 2018).”
MethodCellular and Engineered Organoids for Cardiovascular Models
Thomas, D., Choi, S., Alamana, C., Parker, K. K., & Wu, J. C. (2022) · Circulation Research · doi:10.1161/circresaha.122.320305 · Cited by 100
Self-citationNative cardiac environment and its impact on engineering cardiac tissue
Schwach, V., & Passier, R. C. (2019) · Biomaterials Science · doi:10.1039/c8bm01348a · Cited by 92
Chen, S., Wang, H., McCarthy, A. D., Yan, Z., Kim, H. J., Carlson, M. A., Younan Xia, A., & Xie, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00217 · Cited by 85
Bioengineering approaches to treat the failing heart: from cell biology to 3D printing
Yadid, M., Oved, H., Silberman, E., & Dvir, T. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00603-7 · Cited by 83
Engineering a living cardiac pump on a chip using high-precision fabrication
Michas, C., Karakan, M. Ç., Nautiyal, P., Seidman, J. G., Seidman, C. E., Agarwal, A., Ekinci, K., Eyckmans, J., White, A. E., & Chen, C. S. (2022) · Science Advances · doi:10.1126/sciadv.abm3791 · Cited by 82
Criscione, J. D., Rezaei, Z., Cantu, C. M. H., Murphy, S. A., Shin, S. R., & Kim, D. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114840 · Cited by 83
Microengineered platforms for characterizing the contractile function of in vitro cardiac models
Dou, W., Malhi, M., Zhao, Q., Wang, L., Huang, Z., Law, J., Liu, N., Simmons, C. A., Maynes, J. T., & Sun, Y. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00344-0 · Cited by 83
Chantre, C. O., Gonzalez, G. M., Ahn, S., Cera, L., Campbell, P. H., Hoerstrup, S. P., & Parker, K. K. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b17322 · Cited by 76
Self-citationReconstructing the heart using iPSCs: Engineering strategies and applications
Cho, S., Lee, C., Skylar‐Scott, M. A., Heilshorn, S. C., & Wu, J. C. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.006 · Cited by 73
“ring-shaped EHTs [117,118], and chamber-forming ventricle models [119].”
BackgroundDirect 3D‐Bioprinting of hiPSC‐Derived Cardiomyocytes to Generate Functional Cardiac Tissues
Esser, T. U., Anspach, A., Muenzebrock, K. A., Kah, D., Schrüfer, S., Schenk, J., Heinze, K. G., Schubert, D. W., Fabry, B., & Engel, F. B. (2023) · Advanced Materials · doi:10.1002/adma.202305911 · Cited by 75
Hwang, D. G., Choi, Y., & Jang, J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.685507 · Cited by 74
Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering
Montero, P., Flandes‐Iparraguirre, M., Musquiz, S., Pérez-Araluce, M., Plano, D., Sanmartín, C., Orive, G., Gavira, J. J., Prósper, F., & Mazo, M. M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00955 · Cited by 72
From engineered heart tissue to cardiac organoid
Cho, J., Lee, H., Rah, W., Chang, H., & Yoon, Y. (2022) · Theranostics · doi:10.7150/thno.67661 · Cited by 70
“[66] hiPSC-CMs (1 x 106) M199 plus vitamin B12”
BackgroundMethodInfluentialAlfalfa Nanofibers for Dermal Wound Healing
Ahn, S., Ardoña, H. A. M., Campbell, P. H., Gonzalez, G. M., & Parker, K. K. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b07626 · Cited by 65
Self-citationCurrent challenges in three-dimensional bioprinting heart tissues for cardiac surgery
Roche, C. D., Brereton, R. J. L., Ashton, A. W., Jackson, C., & Gentile, C. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa093 · Cited by 63
Engineering aligned human cardiac muscle using developmentally inspired fibronectin micropatterns
Batalov, I., Jallerat, Q., Kim, S., Bliley, J. M., & Feinberg, A. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-87550-y · Cited by 65
Harnessing organs-on-a-chip to model tissue regeneration
Tavakol, D. N., Fleischer, S., & Vunjak‐Novakovic, G. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.05.008 · Cited by 68
Dwyer, K. D., & Coulombe, K. L. K. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.015 · Cited by 61
Dudek, K. K., Kadic, M., Coulais, C., & Bertoldi, K. (2025) · Nature Reviews Materials · doi:10.1038/s41578-025-00828-9 · Cited by 81
“The ability to program specific shape changes into structures opens up numerous compelling applications in deployable and reconfigurable materials and structures [1, 2, 3, 4], robotics [5, 6, 7], and biomedical devices [8, 9].”
Current Applications of Polycaprolactone as a Scaffold Material for Heart Regeneration
Schmitt, P. R., Dwyer, K. D., & Coulombe, K. L. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00174 · Cited by 60
Extracellular Vesicles in Cardiac Regeneration: Potential Applications for Tissues-on-a-Chip
Wagner, K. T., Nash, T. R., Liu, B., Vunjak‐Novakovic, G., & Radisic, M. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.08.005 · Cited by 49
“Common models include elongated or planar tissues suspended between pillars [41–43], planar tissues attached to flexible substrates [44,45], spheroids [46–48] or tubular tissues [49] in microwells, ring-shaped tissues looped around support posts [50–52], elongated tissues suspended along wire filaments [53], web-like…”
BackgroundA combined human gastruloid model of cardiogenesis and neurogenesis
Olmsted, Z. T., & Paluh, J. L. (2022) · iScience · doi:10.1016/j.isci.2022.104486 · Cited by 58
Park, C., Fan, Y., Hager, G., et al. (2020) · Science Robotics · doi:10.1126/scirobotics.aay9106 · Cited by 53
Standardizing designed and emergent quantitative features in microphysiological systems
Nahon, D. M., Moerkens, R., Aydoğmuş, H., Lendemeijer, B., Martínez-Silgado, A., Stein, J. M., Dostanić, M., Frimat, J., Gontan, C., de Graaf, M. N. S., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01236-0 · Cited by 65
“Steps towards macroscale heart chamber geometries have been made by creating ellipsoidal nanofibrous scaffolds, compatible with microfluidic systems and the application of exogenous pressure, seeded with ventricular cardiomyocytes derived from human induced pluripotent stem cells 15 (hiPSCs).”
Ho, B. X., Pang, J. K. S., Phua, Q. H., Liew, L. C., Poh, B. M., Chen, Y., Loh, Y.-H., An, Ö., Yang, H. H., Seshachalam, V. P., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03215-1 · Cited by 56
Progress in Organ Bioprinting for Regenerative Medicine
Wang, X. S., Zhang, D., Singh, Y. P., Yeo, M., Deng, G., Lai, J., Chen, F., Ozbolat, I. T., & Yu, Y. (2024) · Engineering · doi:10.1016/j.eng.2024.04.023 · Cited by 61
“External interventions such as cellular or extracellular stimuli (e.g., electrical field stimulation and 3D contractile chambers) have also been applied to bioprinted heart models to mimic physiological conditions and accelerate tissue maturation [276–278].”
A framework for developing sex-specific engineered heart models
Lock, R., Al Asafen, H., Fleischer, S., Tamargo, M., Zhao, Y., Radisic, M., & Vunjak-Novakovic, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00381-1 · Cited by 50
Emerging Bioelectronic Strategies for Cardiovascular Tissue Engineering and Implantation
Cox‐Pridmore, D. M., de Castro, F. A., Silva, S. R. P., Camelliti, P., & Zhao, Y. (2022) · Small · doi:10.1002/smll.202105281 · Cited by 51
Macrophages enhance contractile force in iPSC-derived human engineered cardiac tissue
Lock, R. I., Graney, P. L., Tavakol, D. N., Nash, T. R., Kim, Y., Sanchez, E., Morsink, M. A. J., Ning, D., Chen, C., Fleischer, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114302 · Cited by 50
In Vitro Methods to Model Cardiac Mechanobiology in Health and Disease
Jorba, I., Mostert, D., Hermans, L. H. L., van der Pol, A., Kurniawan, N. A., & Bouten, C. V. C. (2021) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2020.0342 · Cited by 51
“By means of advanced 3D bioprinting and electrospinning techniques the characteristic ECM fiber anisotropy has been mimicked while building a left ventricle chamber of few millimeters.(95,96) The scaffolds were seeded with iPSC derived cardiomyocytes and showed functional electrophysiological activity leading to contr…”
MethodMulti-directional cellular alignment in 3D guided by electrohydrodynamically-printed microlattices
Mao, M., He, J., Li, Z., Han, K., & Li, D. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.10.028 · Cited by 48
Recent Advances in Generation of In Vitro Cardiac Organoids
Sahara, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076244 · Cited by 47
“In regards to topics of other in vitro 3D culture models, including various EHT models [16,26], a microfluidics/heart-on-a-chip [27,28], bioprinting [29,30], and electrospinning [31,32], the author asks readers to refer to the suggested reviews, respectively.”
BackgroundSchwach, V., Slaats, R. H., & Passier, R. C. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00050 · Cited by 46
“Similarly, Macqueen and colleagues generated a one cell layer thick ventricular-like tube from hPSCcardiomyocytes (131).”
Methodde Korte, T., Katili, P. A., Yusof, N. A. N. M., van Meer, B. J., Saleem, U., Burton, F. L., Smith, G. L., Clements, P., Mummery, C. L., Eschenhagen, T., et al. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023309 · Cited by 46
Mao, M., Qu, X., Zhang, Y., Gu, B., Li, C., Liu, R., Li, X., Zhu, H., He, J., & Li, D. (2023) · Nature Communications · doi:10.1038/s41467-023-37716-1 · Cited by 42
“Previously, numerous synthetic scaffolds consisting of highly aligned microfabricated grooves or electrospun micro/nano-fi bers have been developed to mimic the anisotropic myocardial architecture, providing the topographical cues to direct cell orientation 15 – 18 .”
Fang, Y., Sun, W., Zhang, T., & Xiong, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121298 · Cited by 40
Engineering anisotropic 3D tubular tissues with flexible thermoresponsive nanofabricated substrates
Williams, N. P., Rhodehamel, M., Yan, C., Smith, A. S. T., Jiao, A., Murry, C. E., Scatena, M., & Kim, D. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119856 · Cited by 41
Fiber Scaffold Patterning for Mending Hearts: 3D Organization Bringing the Next Step
Kristen, M., Ainsworth, M. J., Chirico, N., van der Ven, C. F. T., Doevendans, P. A., Sluijter, J. P. G., Malda, J., van Mil, A., & Castilho, M. D. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900775 · Cited by 40
Sewanan, L. R., & Campbell, S. G. (2019) · The Journal of Physiology · doi:10.1113/jp276753 · Cited by 38
“2016) and even cardiac mini-chamber organoids (MacQueen et al. 2018; Li et al. 2018a) (Fig.”
BackgroundCardiac Organoids: A 3D Technology for Modeling Heart Development and Disease
Zhu, L., Liu, K. Y., Feng, Q., & Liao, Y. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10385-1 · Cited by 43
From tissue engineering to engineering tissues: the role and application of in vitro models
Pacheco, D. P., Vargas, N. S., Visentin, S., & Petrini, P. (2020) · Biomaterials Science · doi:10.1039/d0bm01097a · Cited by 37
Homma, J., Shimizu, S., Sekine, H., Matsuura, K., & Shimizu, T. (2020) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3074 · Cited by 33
“…the seeding of cells on aligned nanofibers and culture for several days (Han, Wu, Xia, Wagner, & Xu, 2016; Li et al., 2017; Lin et al., 2014; MacQueen et al., 2018), the seeding of cells on a matrix in a patterned mold (Nakane et al., 2017), and the seeding of cells into a collagen gel…”
BackgroundMethodEngineering and Assessing Cardiac Tissue Complexity
Tadevosyan, K., Iglesias‐García, O., Mazo, M. M., Prósper, F., & Raya, Á. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031479 · Cited by 35
“The authors showed that cells aligned following the fiber orientation, thus recapitulating the orientation of the native myocardium, although the contractile function was much smaller than those of the native rat/human ventricles most likely owing to the small thickness of the chamber [203].”
BackgroundProgress in Bioengineering Strategies for Heart Regenerative Medicine
Häneke, T., & Sahara, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073482 · Cited by 32
“ning [145,146], Microfluidic chip [151], Muscle strip (ring shaped EHT) [40], Dynamic culture (cardiobundles) [137], Micro heart muscle arrays [76], BiowireTM [45,152]; 4.”
BackgroundBuilding an Artificial Cardiac Microenvironment: A Focus on the Extracellular Matrix
Pagliarosi, O., Picchio, V., Chimenti, I., Messina, E., & Gaetani, R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559032 · Cited by 34
Melle, G., Bruno, G., Maccaferri, N., Iachetta, G., Colistra, N., Barbaglia, A., Dipalo, M., & Angelis, F. D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00066 · Cited by 34
“058 m·s−1, which is comparable to values measured for the same cells in other works (Macqueen et al., 2018).”
ResultInfluentialWhole-Heart Tissue Engineering and Cardiac Patches: Challenges and Promises
Akbarzadeh, A., Sobhani, S., Khaboushan, A. S., & Kajbafzadeh, A. M. (2023) · Bioengineering · doi:10.3390/bioengineering10010106 · Cited by 32
“The ejection fractions and contractile work were ~50–250 and ~104–108 smaller than the physiologic values rodent and human ventricles, respectively [50].”
BackgroundA Change of Heart: Human Cardiac Tissue Engineering as a Platform for Drug Development
Bremner, S. B., Gaffney, K. S., Sniadecki, N. J., & Mack, D. L. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01668-7 · Cited by 29
de Almeida, H. V., Tenreiro, M. F., Louro, A. F., Abecasis, B., Santinha, D. R., Calmeiro, T., Fortunato, E. M. C., Ferreira, L., Alves, P. M., & Serra, M. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01490 · Cited by 32
The harder the climb the better the view: The impact of substrate stiffness on cardiomyocyte fate
Querceto, S., Santoro, R., Gowran, A., Grandinetti, B., Pompilio, G., Regnier, M., Tesi, C., Poggesi, C., Ferrantini, C., & Pioner, J. M. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.02.001 · Cited by 37
Wu, Q., Xue, R., Zhao, Y., Ramsay, K., Wang, E. Y., Savoji, H., Veres, T., Cartmell, S. H., & Radisic, M. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.019 · Cited by 27
“Ultimately, the engineered human left ventricle [73,74], and a 3D bioprinted ventricle model [75] may replace trabeculae-like structures in drug development and disease modelling, due to their conceptual ability to predict ventricle dilatation and remodeling, as well as the ability to capture…”
BackgroundTissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing
Donoghue, L., Nguyen, K. T. V., Graham, C., & Sethu, P. (2021) · Micromachines · doi:10.3390/mi12020139 · Cited by 31
“fabricated models of the left ventricle that more accurately mimicked ellipsoidal ventricular geometry via the pull-spinning of biocompatible, biodegradable polycaprolactone/gelatin nanofibers [61].”
MethodCardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies
Seguret, M., Vermersch, E., Jouve, C., & Hulot, J. (2021) · Biomedicines · doi:10.3390/biomedicines9050563 · Cited by 28
Mohammadi, M. H., Okhovatian, S., Savoji, H., Campbell, S. B., Lai, B. F. L., Wu, J., Pascual‐Gil, S., Bannerman, D., Rafatian, N., Li, R., et al. (2022) · Advanced Biology · doi:10.1002/adbi.202101165 · Cited by 28
Tissue-engineered heart chambers as a platform technology for drug discovery and disease modeling
Mousavi, A., Stefanek, E., Jafari, A., Ajji, Z., Naghieh, S., Akbari, M., & Savoji, H. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212916 · Cited by 27
Soft bioelectronics for cardiac interfaces
Tang, X., He, Y., & Jia Liu, B. (2022) · Biophysics Reviews · doi:10.1063/5.0069516 · Cited by 25
Wu, H., Shi, S., Liu, Y., Zhang, Q., Lam, R. H. W., Lim, C. T., & Hu, J. (2023) · Biofabrication · doi:10.1088/1758-5090/acdaf9 · Cited by 23
“Isoproterenol, a synthetic catecholamine, restores cardiomyocyte beating by inducing positive inotropic and chronotropic responses [147, 148].”
Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells
James, E. C., Tomaskovic‐Crook, E., & Crook, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063005 · Cited by 25
Lee, J., Park, D., Seo, Y., Chung, J. J., Jung, Y., & Kim, S. H. (2020) · Advanced Materials · doi:10.1002/adma.202002096 · Cited by 24
Stem Cells and Their Cardiac Derivatives for Cardiac Tissue Engineering and Regenerative Medicine
Roshanbinfar, K., Esser, T. U., & Engel, F. B. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8193 · Cited by 25
“Inpreclinicaltrials,sixadult Yucata´npigsandfouradultmongreldogswere subjectedto‘‘fullthicknesscirculardefects’’and treatedwithsmallintestinalsubmucosa-ECM.”
InfluentialModelling genetic diseases for drug development: Hypertrophic cardiomyopathy
Santini, L., Palandri, C., Nediani, C., Cerbai, E., & Coppini, R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105176 · Cited by 24
“Among the different tools used to study the heart in depth [200], cell culture is fundamental to understand multiple mechanisms responsible for cell behavior in vivo, uncovering different”
MethodDaly, A. C., Davidson, M. D., & Burdick, J. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.21.103127 · Cited by 24
Engineering biomimetic and instructive materials for wound healing and regeneration
Chantre, C. O., Hoerstrup, S. P., & Parker, K. K. (2019) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2019.04.004 · Cited by 32
Self-citationMao, M., Han, K., Gao, J., Ren, Z., Zhang, Y., He, J., & Li, D. (2025) · Advanced Materials · doi:10.1002/adma.202419380 · Cited by 25
Lou, L., Rubfiaro, A. S., Deng, V., He, J. M., Thomas, T., Roy, M., Dickerson, D. A., & Agarwal, A. K. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c06505 · Cited by 25
Cardiac fibroblast BAG3 regulates TGFBR2 signaling and fibrosis in dilated cardiomyopathy
Wang, B. Z., Morsink, M. A. J., Kim, S. W., Luo, L. J., Zhang, X., Soni, R. K., Lock, R. I., Rao, J., Kim, Y., Zhang, A., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci181630 · Cited by 22
“Our laboratory and others have demonstrated the ability of hiPSC-based engineered tissues to model cardiac development, elucidate normal and pathological function, and parse out the respective contributions of CMs and supporting cells (21–25).”
Reactive Cell Electrospinning of Anisotropically Aligned and Bilayer Hydrogel Nanofiber Networks
Dawson, C. J., Xu, F., & Hoare, T. R. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01013 · Cited by 24
Developmental co-emergence of cardiac and gut tissues modeled by human iPSC-derived organoidsPreprint
Silva, A. C., Rubio, O., Joy, D. A., Kauss, M. A., Natarajan, V., Lai, M. H., Turaga, D., Blair, A. P., Alexanian, M., Bruneau, B. G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.30.071472 · Cited by 21
Gu, B., Han, K., Cao, H., Huang, X., Li, X., Mao, M., Zhu, H., Cai, H., Li, D., & He, J. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100914 · Cited by 23
“9D) [112].”
Engineering Heart Morphogenesis
Mandrycky, C., Williams, N. P., Batalov, I., El‐Nachef, D., de Bakker, B. S., Davis, J., Kim, D., DeForest, C. A., Zheng, Y. Y., Stevens, K. R., et al. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.01.006 · Cited by 21
Fabrication of human myocardium using multidimensional modelling of engineered tissues
Montero‐Calle, P., Flandes‐Iparraguirre, M., Mountris, K. A., Nava, A., Laita, N., Rosales, R. M., Iglesias‐García, O., De‐Juan‐Pardo, E. M., Atienza, F., Fernández‐Santos, M. E., et al. (2022) · Biofabrication · doi:10.1088/1758-5090/ac8cb3 · Cited by 20
Modeling Cardiac Arrhythmias With Organoids
Hulot, J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.076 · Cited by 18
A perspective on the use of light as a driving element for bio-hybrid actuation
Vurro, V., Venturino, I., & Lanzani, G. (2022) · Applied Physics Letters · doi:10.1063/5.0078411 · Cited by 15
Colzani, M., Malcor, J.-D. M., Hunter, E. J., Bayraktar, S., Polkinghorne, M., Krieg, T., Cameron, R. E., Best, S. M., Farndale, R. W., & Sinha, S. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120612 · Cited by 17
Dwyer, K. D., Kant, R. J., Soepriatna, A. H., Roser, S. M., Daley, M. C., Sabe, S. A., Xu, C., Choi, B., Sellke, F. W., & Coulombe, K. L. K. (2023) · Bioengineering · doi:10.3390/bioengineering10050587 · Cited by 17
Deidda, V., Ventisette, I., Langione, M., Giammarino, L., Pioner, J. M., Credi, C., & Carpi, F. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15100297 · Cited by 16
“…the ability of pluripotent stem cells (PSCs) to differentiate into all tissue types, including cardiac cells; indeed, their use in combination with new biomaterials, capable of emulating the behaviour of the extracellular matrix, represents a new frontier in the realm of cardiac regeneration [2,3].”
BackgroundCyr, J. A., Colzani, M., Bayraktar, S., Köhne, M., Bax, D. V., Graup, V., Farndale, R. W., Sinha, S., Best, S. M., & Cameron, R. E. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213680 · Cited by 17
“Calcium fluorescence patterns serve as a surrogate for action potential propagation and describe excitation-contraction coupling kinetics [20,27].”
BackgroundWhole Heart Engineering: Advances and Challenges
Morrissey, J., Mesquita, F., Hochman‐Mendez, C., & Taylor, D. A. (2021) · Cells Tissues Organs · doi:10.1159/000511382 · Cited by 14
“tion) in the produced constructs remains crude [MacQueen et al., 2018].”
BackgroundConstantinou, C., Miranda, A. M. A., Cháves, P., Bellahcene, M., Massaia, A., Cheng, K., Samari, S., ROTHERY, S. M., Chandler, A. M., Schwarz, R. P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69495-w · Cited by 14
Multi-cellularity in cardiac tissue engineering, how close are we to native heart tissue?
Owen, T. J., & Harding, S. E. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09528-8 · Cited by 14
Parvatam, S., Pamies, D., Pistollato, F., Beken, S., Mariappan, I., Roth, A. B., Piergiovanni, M., Maisonneuve, B. G. C., Ewart, L. C., Majumder, A., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.11.008 · Cited by 17
Metadata
- Authors
- MacQueen, L. A., Sheehy, S. P., Chantre, C. O., Zimmerman, J. F., Pasqualini, F. S., Liu, X., Goss, J. A., Campbell, P. H., Gonzalez, G. M., Park, S.-J., Capulli, A. K., Ferrier, J. P., Kosar, T. F., Mahadevan, L., Pu, W. T., & Parker, K. K.
- Affiliations
- Harvard University (US)
- Boston Children's Hospital (US)
- Corresponding author
- Parker, Kevin Kit
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2018-07-23
- Volume
- 2
- Issue
- 12
- Pages
- 930-941
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC6774355
- OpenAlex
- W2884444313
- Semantic Scholar
- fe2a5e78ca3d5d351aa428f530fae947c66402fc
- Cited by
- 227
- References
- 84
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 27 · 2023: 30 · 2022: 41 · 2021: 34 · 2020: 35 · 2019: 21 · 2018: 2
- FWCI
- 23.91
- Type
- journal article
- Language
- en
- Update notices
- addendum (2022-03-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UH3TR000522)
- National Heart, Lung, and Blood Institute (UH3HL141798, UG3HL141798)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- left ventricle, nanofibrous scaffolds, cardiomyocytes, iPSC-derived cardiomyocytes, ejection fraction, pressure-volume loops, ventricular assist, bioreactors
- MeSH terms
- Animals, Arrhythmias, Cardiac, Extracellular Matrix, Heart Ventricles, Humans, Models, Biological, Myocardial Contraction, Polymers, Ventricular Function, Computer-Aided Design, Rats, Sprague-Dawley, Tissue Engineering, Myocytes, Cardiac, Rats, Tissue Scaffolds, Induced Pluripotent Stem Cells, Nanofibers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review